Lilly puts $700M into genetic medicine institute

Bio Pharma Dive

Building on Lilly's acquisition of Prevail Therapeutics, the Boston-based facility will use RNA- and DNA-based technologies to develop new drugs, while also supporting biotech startups in the area

Bayer, Amgen back ReCode's plan to broaden genetic medicine's reach

Bio Pharma Dive

The two drugmakers joined a long list of investors, including Pfizer and Sanofi, that have been funding the startup’s plan to develop a new type of lipid nanoparticle technology

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FDA sets out advice to developers of gene editing medicines

Bio Pharma Dive

Draft recommendations from the agency were generally straightforward, analysts said, although the document emphasized the potential safety risks of gene editing

Nanochannels light the way towards new medicine

Scienmag

Social & Behavioral Science light Medicine nanochannelsTo develop new drugs and vaccines, detailed knowledge about nature’s smallest biological building blocks – the biomolecules – is required.

DNA 83

Microbiota medicine: towards clinical revolution

Scienmag

Biology clinical Medicine microbiota revolutionAfter the last meeting of the International Society of Microbiota (ISM), a well-documented report and statement were published.

Pfizer pledges not-for-profit sale of medicines in low-income countries

Bio Pharma Dive

The new initiative commits Pfizer to supplying current and future branded medicines at lower cost to 45 countries The pharma has been criticized for not doing enough to make its COVID-19 vaccine and pill available globally.

Sales 199

When medicine is not enough for schizophrenia and psychosis

Scienmag

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “When Medicine is Not Enough for Schizophrenia and Psychosis” on Tuesday, July 12, 2022, at 2:00 pm EDT. Chemistry AND Physics Medicine psychosis schizophrenia

Pfizer buys into Biohaven's fast-selling migraine medicine

Bio Pharma Dive

The pharmaceutical giant will pay Biohaven $500 million for ex-U.S. rights to rimegepant — a sizable licensing deal, though not the buyout that some of the biotech's investors appeared to be hoping for

Blueprint Medicines announces financing partnerships for $1.25bn

Pharmaceutical Technology

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. The post Blueprint Medicines announces financing partnerships for $1.25bn appeared first on Pharmaceutical Technology.

A new startup gets Takeda's backing to take complex genetic medicines 'off the shelf'

Bio Pharma Dive

Ensoma Therapeutics debuts with a lucrative alliance with the Japanese pharma and an unusual way to deliver genetic medicines into the body

German Merck buys manufacturer of key component in mRNA medicines

Bio Pharma Dive

Merck KGaA is buying Indianapolis-based Exelead, a specialist in the lipid nanoparticles used to ferry mRNA into the body, for $780 million in cash

Lilly pays $880M for Prevail, pushing further into genetic medicine

Bio Pharma Dive

The acquisition marks a significant bet by Lilly on gene therapy's potential to address tough-to-treat neurological disorders like Parkinson's disease

Towards precision medicine for dialysis patients

Scienmag

Biology dialysis Medicine Patients precisionEvery day, the human kidneys clean about 1,500 liters of blood by producing approximately 1–2 liters of urine.

SNMMI launches Mars Shot Fund for nuclear medicine research; initial donations top $600,000

Scienmag

Reston, VA — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) today announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.

Moving away from genetic continental ancestry categories in research and medicine

Scienmag

Latest News ancestry categories continental genetic Medicine moving research

Prime Medicine raises $315M to fuel 'search-and-replace' gene editing work

Bio Pharma Dive

Formed around research from the Broad Institute's David Liu and Andrew Anzalone, Prime has attracted significant funding from a wide range of high-profile biotech backers

Penn Medicine awarded $9 million to advance study of technology that lights up lung cancer tumors

Scienmag

PHILADELPHIA— Building on Penn Medicine’s years of research and use of imaging technology that illuminates tumor tissue—helping clinicians more easily detect and remove it—the Perelman School of Medicine at the University of Pennsylvania has received a five-year, $9 million research grant from the National Cancer Institute (NCI) to push the field forward, particularly for lung cancer patients. […].

Sanoff offers perspective on a promising rectal cancer study in the New England Journal of Medicine

Scienmag

Sanoff, MD, MPH, is the author of a viewpoint in the New England Journal of Medicine that provides a perspective on the evolving treatment of rectal cancer. Cancer cancer England journal Medicine offers perspective promising rectal Sanoff study

Easy-to-take medicine better at suppressing HIV in children

Scienmag

Social & Behavioral Science children Easytotake HIV Medicine suppressing

Foundation Medicine Announces Strategic Collaboration with Arvinas

BioTech 365

Albert Einstein College of Medicine and Montefiore Health System receive federal grant to expand addiction medicine education and training

Scienmag

December 16, 2021—(BRONX, NY)—Albert Einstein College of Medicine and Montefiore Health System have been awarded a three-year, $447,000 grant to grow their addiction medicine education and training programs for medical students and residents.

Should e-cigarettes be licensed as medicines?

Scienmag

Latest News Ecigarettes licensed MedicinesNicholas Hopkinson at Imperial College London welcomes the move, saying this will give doctors another means to help smokers quit. E-cigarettes are currently regulated as consumer products so cannot be promoted as smoking cessation aids, he explains. Yet a Cochrane review already supports existing e-cigarettes as a smoking cessation aid, as does recently updated guidance […].

Taking stock of NHS medicines optimisation

Pharma Phorum

Given the rising cost of medicines as a share of the NHS budget in England, the establishment of ICSs provides a timely opportunity to take stock on delivering medicines optimisation at local level, says NHS Gloucestershire CCG’s Ellen Rule. Building a ‘One Medicines Team’.

Organicell on regenerative medicine: the pharmaphorum podcast

Pharma Phorum

In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine. The post Organicell on regenerative medicine: the pharmaphorum podcast appeared first on.

Bioengineered hybrid muscle fiber for regenerative medicine

Scienmag

Chemistry AND Physics Biomechanics/Biophysics Cell Biology Medicine/Health Musculature Orthopedic Medicine Physiology Rehabilitation/Prosthetics/Plastic Surgery Trauma/Injury

Venture capital pours more money into RNA medicines with the launch of Replicate

Bio Pharma Dive

The company, which focuses on self-replicating RNA, comes equipped with $40 million from Apple Tree Partners and a stamp of approval from the former research head at Biogen

RNA 214

Some blood pressure medicine may decrease the aneurysm rupture risk for people with high blood pressure

Scienmag

Latest News aneurysm blood decrease high Medicine people pressure risk ruptureEmbargoed until 4 a.m. CT/5 a.m.

Amgen, expecting higher demand for its medicines, to build plant in North Carolina

Bio Pharma Dive

The biotech is also constructing a new factory in Ohio and, between the two, expects to investment nearly $1 billion over the next few years

Students win kudos for sports medicine research

Scienmag

– UMass Lowell students testing a new device that could transform the way heart-rate data is collected have won praise for their work from the American College of Sports Medicine. SCIENCE EDUCATION Cardiology Diagnostics Graduate/Postgraduate Education Health Care Medicine/Health Neurobiology Public Health Pulmonary/Respiratory Medicine Sports Medicine UndergraduateStudy of heart-rate sensor earns praise for UMass Lowell team LOWELL, Mass.

Clearmind Medicine Appoints New Chief Financial Officer

BioTech 365

Clearmind Medicine Appoints New Chief Financial Officer Clearmind Medicine Appoints New Chief Financial Officer VANCOUVER, June 15, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on … Continue reading → GlobeNewswire

Penn Medicine neurologist wins Barancik Prize for Innovation in MS Research

Scienmag

Medicine & Health Barancik innovation Medicine neurologist Penn Prize research wins

Penn Medicine study reveals imaging approach with potential to detect lung cancer earlier, at the cellular level

Scienmag

Medicine & Health approach cancer cellular detect earlier imaging level lung Medicine Penn potential reveals study

Are medicines affecting our response to infections like COVID-19?

Scienmag

The largest clinical review of immune responses to paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs) and opioid analgesics, with a focus on infectious diseases, has provided insights into unintended impacts of these commonly used medicines. The findings highlight the potential for some of these medicines to join the fight against old and new infectious diseases. Latest News affecting COVID19 infections Medicines response

Journal of Nuclear Medicine impact factor surges more than 27%

Scienmag

JNM ranks third among all medical imaging journals Credit: SNMMI The Journal of Nuclear Medicine has again achieved the highest impact factor ever in its history, now ranking third among all medical journals worldwide, according to new data just released in the 2020 Journal Citation Reports.

Pushing Beyond Gene Editing Limits with Programmable RNA Medicines

BioSpace

Shape Therapeutics is evolving programmable RNA medicines that push the limits of current gene editing capabilities. BioSpace spoke with CSO David Huss

GSK partners LifeMine on fungi-derived medicines

Pharma Phorum

There’s a rich history of finding useful medicines from fungi, from the antibiotic penicillin to immune suppressant cyclosporine and cholesterol drug lovastatin. The post GSK partners LifeMine on fungi-derived medicines appeared first on.

American College of Lifestyle Medicine launches one-hour online CME/CE “Introduction to lifestyle medicine” course for medical professionals

Scienmag

The American College of Lifestyle Medicine (ACLM), the medical professional society that since its inception in 2004 has filled the void in medical education about evidence-based lifestyle intervention for chronic disease, today announced the availability of a new one-hour CME/CE course for medical professionals, “Introduction to Lifestyle Medicine.” Latest News American CMECE College introduction launches lifestyle medical Medicine onehour online Professionals

Multi-algorithm approach helps deliver personalized medicine for cancer patients

Scienmag

Biology approach cancer deliver helps Medicine Multialgorithm Patients personalizedToday, machine learning, artificial intelligence, and algorithmic advancements made by research scientists and engineers are driving more targeted medical therapies through the power of prediction.

Artificial intelligence stands to transform precision medicine: AiCure

Outsourcing Pharma

An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior. Patient centricity

Essential Medicines and Patents

Drug Patent Watch

Mark Schultz and Jaci McDole recently used DrugPatentWatch to complete a report on recent trends in the latest editions of the world health organization essential medicines list. The post Essential Medicines and Patents appeared first on DrugPatentWatch - Make Better Decisions.

Wishing You More Affordable Medicine This Christmas

Pharmacy Checkers

With some stops and starts, this blog has become far more focused on policy, regulatory matters, law and politics — and less on everyday consumer issues relating to drug prices.

Technological Innovation: The Medicine of Healthcare

Delveinsight

A mutual symbiotic relationship is formed between the two domains, where with the help of technology new discoveries can be made in the field of medicine for the sole purpose of helping people.

Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up

Bio Pharma Dive

The approval for the FoundationOne Liquid CDx follows the agency's nod earlier this month for Guardant Health's next-generation sequencing diagnostic